Ok, so, let me get this straight.
KODAK decides it is going to get into the pharmaceutical game, probably to snag some more Cooties TARP 7.0 money.
Kodak C.E.O. Got Stock Options Day Before News of Loan Sent Stock Soaring
Then, it accidentally leaks out a presser to the local newspaper on how it is going to get funded to start playing in the pharmaceutical game.
Kodak Under SEC Scrutiny Over Early Disclosure of U.S. Loan Plan
Then, since only their selectively chosen audience received the accidentally released presser on the investment, stock prices soared from $2.00 a share to $60.00 a share, overnight.
But, during the maximum price peak, some of the top executives and their in-laws, in the midst of the stock price climax, ejaculates its shares either by sale or tax write off to a local synagogue.
Then, word got out and the stock price dropped back to $9.00 a share and now there is an FEC investigation.
So, my question would be, which tiny human trust funds of stealin' the children, land & vote were the financial vehicles and what kind of fraud schemes were funded for purposes of laundering the money.
Kodak deal with US government to produce pharmaceuticals appears to be on hold
The US DFC tweeted that ‘recent allegations of wrongdoing raise serious concerns’
An agreement between the US government and Kodak to develop generic drug ingredients appears to be on hold, after the US International Development Finance Corporation tweeted that “recent allegations of wrongdoing raise serious concerns.”
“We will not proceed any further unless these allegations are cleared,” the agency tweeted, without specifying what the allegations were.
On July 28, we signed a Letter of Interest with Eastman Kodak. Recent allegations of wrongdoing raise serious concerns. We will not proceed any further unless these allegations are cleared.— DFCgov (@DFCgov) August 7, 2020
Kodak said Friday it was conducting an internal review of recent activity by the company in connection with a $765 million loan it would receive under the Defense Production Act to produce pharmaceuticals. The company’s stock price surged in the days before the deal was announced, CBS News reported, leading Sen. Elizabeth Warren (D-MA) to call for the Securities and Exchange Commission to investigate whether there were any instances of insider trading.
Kodak, best known for its camera and film equipment, said it planned to create a new business arm called Kodak Pharmaceuticals to make ingredients that have “lapsed into chronic national shortage.” Kodak CEO Jim Continenza told The Wall Street Journal that he expected pharmaceuticals to become 30 to 40 percent of the company’s business. The company’s plans included production of ingredients for drugs such as hydroxychloroquine, according to The Wall Street Journal. President Trump has touted hydroxychloroquine as a possible treatment for COVID-19, despite evidence that the anti-malaria drug has been ineffective against the virus.
Rep. Maxine Waters (D-CA), chair of the House Financial Services Committee and other Democrats sent a letter to DFC head Adam Boehler August 4th asking why the agency was supporting a loan for Kodak, “an organization that was on the brink of failure in 2012 and was unsuccessful in its previous foray into pharmaceutical manufacturing, in its efforts to develop the capacity to produce up to 25 percent of domestic pharmaceutical components.” The committee is asking to see all communications concerning the loan.
Voting is beautiful, be beautiful ~ vote.©
No comments:
Post a Comment